Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Runx2/Cbfa1: a multifunctional regulator of bone formation.

J B Lian1, G S Stein

  • 1Department of Cell Biology and Cancer Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA. jane.lian@umassmed.edu

Current Pharmaceutical Design
|October 8, 2003
PubMed
Summary

Runx2 is a key transcription factor crucial for bone formation and osteoblast differentiation. Understanding its regulation offers potential for new bone-building therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer.

Genes, chromosomes & cancer·2019
Same author

DLX3 regulates bone mass by targeting genes supporting osteoblast differentiation and mineral homeostasis in vivo.

Cell death and differentiation·2014
Same author

Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance.

British journal of cancer·2012
Same author

Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.

British journal of cancer·2011
Same author

The Role of RUNX2 in Osteosarcoma Oncogenesis.

Sarcoma·2011
Same author

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.

Oncogene·2009

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • Runx2 (Runt-related transcription factor 2) is a critical transcription factor.
  • It belongs to the runt homology domain family.
  • Runx2 is essential for osteoblast differentiation and bone formation.

Purpose of the Study:

  • To review the molecular mechanisms of Runx2 in osteoblastogenesis.
  • To highlight Runx2's role in regulating tissue-specific genes.
  • To explore therapeutic strategies targeting Runx2 for bone formation.

Main Methods:

  • Literature review of studies on Runx2 function.
  • Analysis of Runx2's role in skeletogenesis.
  • Examination of pathways regulating bone formation and turnover.

Related Experiment Videos

Main Results:

  • Runx2 acts as a master regulatory gene for osteoblastogenesis.
  • It controls osteoblast growth, differentiation, and skeletogenesis.
  • Runx2 integrates complex pathways for bone remodeling.

Conclusions:

  • Defining Runx2's molecular mechanisms provides insights into transcriptional regulation.
  • Regulation of Runx2 expression is a potential basis for novel bone therapeutic strategies.
  • Runx2's unique properties are vital for skeletal development and maintenance.